Coherent Corp. director Enrico Digirolomo sells $1.6 million in shares

Coherent director Enrico Digirolomo sold 5,315 shares for $1.63 million at $305.99 per share on September 11, while retaining direct beneficial ownership of 10,644 shares; the stock was recently trading at $271.17 after a 160% one-year gain. Separately, Coherent posted record fiscal Q4 2026 revenue of $2.05 billion versus $1.99 billion consensus and adjusted EPS of $1.74 versus $1.62 expected, with adjusted gross margin rising 210bps year over year to 40.2%. Fiscal Q1 2027 guidance exceeded revenue expectations by 8% and EPS expectations by $0.05, supported by datacenter optical-product demand expected to exceed supply for 12-18 months.

Analysis

COHR’s near-term setup is governed less by demand discovery than by conversion of backlog into qualified optical-module shipments. The key upside is operating leverage: incremental datacenter mix can expand gross margin faster than revenue if yields and utilization hold. The offset is that a supply-constrained position can shift the bottleneck to internal capacity, substrates, packaging equipment, and customer qualification cycles; incremental capex would be positive for revenue durability but may defer free-cash-flow conversion over the next 2-4 quarters.

The insider disposition is not independently informative without a 10b5-1 plan history, total insider liquidity, and peer transaction context. More importantly, the sale price materially above the current quote creates a potential technical overhead zone, while upward estimate revisions leave little room for a modest guide-down. The next 1-3 month catalyst path is order visibility, lead-time commentary, and evidence that customers are accepting price increases or deposits rather than merely placing nonbinding reservations.

Competitive spillovers favor LITE and AAOI if hyperscaler optical demand is broad-based and COHR cannot add qualified capacity quickly; both can capture urgent second-source demand, although neither necessarily matches COHR’s product breadth. Contrarily, consensus may be underestimating the value of scarcity if supply remains tight through multiple customer planning cycles: constrained supply can support price discipline and reduce the usual optical-component boom/bust inventory correction. The thesis fails if bookings normalize, inventory days rise, gross margin stalls despite mix improvement, or capacity expansion materially outpaces committed demand over the next 6-18 months.

Key Decisions for Investors

• Accumulate COHR only on evidence of support above the recent post-results trading range and after confirming no adverse 10b5-1/insider-pattern signal; target a 6-12 month hold through capacity and booking updates. Underwrite upside from sustained margin/estimate revisions rather than the published analyst targets; exit on a material reduction in lead-time or pricing commentary.
• Run a 1-3 month relative-value basket: long COHR and LITE versus a short broad semiconductor proxy such as SOXX, sized beta-neutral. This isolates optical/datacenter demand from rate-driven multiple compression; close if the next earnings cycle shows optical bookings decelerating across both names.
• Add AAOI to a watchlist rather than initiating immediately: it is the higher-beta second-source beneficiary if COHR’s supply constraint produces customer reallocation. Require confirmation through AAOI order commentary and gross-margin guidance before entry, since supplier qualification and execution risk can overwhelm the demand signal.
• Do not treat the director sale as a standalone short catalyst. Reassess downside positioning only if additional executives sell into strength, the company discloses expanded capacity without corresponding committed demand, or consensus revenue/EPS estimates stop rising despite strong shipment commentary.